These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 10441137)
1. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137 [TBL] [Abstract][Full Text] [Related]
2. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
3. [Involvement of beta-amyloid in the etiology of Alzheimer's disease]. Tomiyama T Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873 [TBL] [Abstract][Full Text] [Related]
4. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease. Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995 [TBL] [Abstract][Full Text] [Related]
5. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease. Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562 [TBL] [Abstract][Full Text] [Related]
6. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
7. In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. Esler WP; Stimson ER; Ghilardi JR; Vinters HV; Lee JP; Mantyh PW; Maggio JE Biochemistry; 1996 Jan; 35(3):749-57. PubMed ID: 8547255 [TBL] [Abstract][Full Text] [Related]
8. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template. Ha C; Park CB Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248 [TBL] [Abstract][Full Text] [Related]
9. Amyloid-beta aggregation. Finder VH; Glockshuber R Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215 [TBL] [Abstract][Full Text] [Related]
10. Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. Esler WP; Stimson ER; Ghilardi JR; Lu YA; Felix AM; Vinters HV; Mantyh PW; Lee JP; Maggio JE Biochemistry; 1996 Nov; 35(44):13914-21. PubMed ID: 8909288 [TBL] [Abstract][Full Text] [Related]
11. Activation barriers to structural transition determine deposition rates of Alzheimer's disease a beta amyloid. Esler WP; Felix AM; Stimson ER; Lachenmann MJ; Ghilardi JR; Lu YA; Vinters HV; Mantyh PW; Lee JP; Maggio JE J Struct Biol; 2000 Jun; 130(2-3):174-83. PubMed ID: 10940224 [TBL] [Abstract][Full Text] [Related]
12. Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Harigaya Y; Saido TC; Eckman CB; Prada CM; Shoji M; Younkin SG Biochem Biophys Res Commun; 2000 Sep; 276(2):422-7. PubMed ID: 11027491 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020 [TBL] [Abstract][Full Text] [Related]
14. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J; Selkoe DJ Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773 [TBL] [Abstract][Full Text] [Related]
15. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Ha C; Ryu J; Park CB Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909 [TBL] [Abstract][Full Text] [Related]
16. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model. Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481 [TBL] [Abstract][Full Text] [Related]
17. Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques. Prior R; D'Urso D; Frank R; Prikulis I; Cleven S; Ihl R; Pavlakovic G Am J Pathol; 1996 Jun; 148(6):1749-56. PubMed ID: 8669461 [TBL] [Abstract][Full Text] [Related]
18. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224 [TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931 [TBL] [Abstract][Full Text] [Related]
20. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease. Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]